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Introduction
In proton magnetic resonance spectroscopy ( 1 H-MRS) of the and Ogino, 1993). Prominent physiological macromolecular resonances detected on such localized metabolite-nulled brain, separation of macromolecules (proteins and lipids) from metabolites with low molecular weight, such as lactate 1 H magnetic resonance spectra have been described at 0.93, 1.24, 1.43, 2.05 and 3.00 parts per million (p.p.m.) (Behar (Lac), N-acetyl-aspartate (NAA), creatine (Cr), choline (Cho), myo-inositol (MI) and glutamine and glutamate (Glx), is et al., 1994) . Discrimination of metabolites from elevated macromolecular resonances in acute stroke (Hwang et al. , achieved by the metabolite-nulling technique according to different T 1 relaxation times, as shown in Fig. 1 (Behar 1996; Saunders et al., 1997) and human brain tumours has Koopmans et al., 1993; Roser et al., 1996) . In none of the studies was any outer volume saturation performed to exclude lipid contamination from the fat-containing structures of the skull and galea. Narayana and colleagues (Narayana et al., 1992) and Davie and colleagues (Davie et al., 1994) discussed this lipid contamination from outside the volume of interest (VOI) and thought it to be dependent on the distance between scalp and VOI. Seeger and colleagues, however, demonstrated that considerable lipid contamination was not dependent on that distance, and stressed the importance of outer volume saturation in single-voxel spectroscopy (Seeger et al., 2000) . Furthermore, no quantitative determination of the macromolecules has yet been performed in any pathological condition.
In the present study, the metabolite-nulling technique was applied to acute and chronic multiple sclerosis lesions. By differentiating between macromolecules and overlying metabolites, we predicted the detection of macromolecules in acute lesions. Outer volume saturation was performed in order to achieve reliable detection and evaluation of the macromolecule resonances. Quantitation was achieved by a modified version of the LCModel software (Provencher et al., 1993) .
Methods

Subjects
We studied 10 patients with acute multiple sclerosis lesions (four men, six women, median age 30.5 years, range 22-39 years), 10 patients with chronic lesions (two men, eight women, median age 34.5 years, range 21-54 years) and 10 healthy control subjects (six men, four women, median age 27 years, range 19-62 years). ordinate, magnetization. After an antecedent inversion pulse, the Of the ten patients with acute lesions, eight had clinically longitudinal magnetization is inverted. Because of the longer T 1 definite multiple sclerosis and two had laboratory-supported relaxation time of the metabolites, the amount of longitudinal magnetization of the metabolites is zero at the beginning of definite multiple sclerosis (Poser et al., 1983) . The mean STEAM excitation (arrow). At this time the longitudinal duration of neurological symptoms before 1 H-MRS ranged magnetization of the macromolecules has already recovered nearly from 1 to 18 days (mean 6 days). All acute lesions showed fully, resulting in a spectrum in which only macromolecules are contrast enhancement on T 1 -weighted images. showed a contrast-enhancing lesion on T 1 -weighted images.
2.1 and 3.0 p.p.m. are visible without overlaying metabolites.
Eight patients with acute lesions had not received corticosteroid treatment and two had received corticosteroids for 2 been reported (Howe et al., 1995) . Prior to the present study, and 3 days in advance of 1 H-MRS. Effects of corticosteroids there have been no published reports of the application of on the spectra were examined by measurements performed the metabolite-nulling technique to multiple sclerosis.
before and on day 5 of a 5-day course of corticosteroid Differentiation between metabolites and macromolecules treatment (500 mg methylprednisolone/day) and 7 days after (lipids and proteins) has become important in acute and the last dose. chronic multiple sclerosis because in the past the detection The procedure was approved by the 'Ethik-Kommission der of elevated signals in the spectral region of lipids in acute Medizinischen Fakultät des Universitätsklinikums Tübingen', multiple sclerosis lesions has been interpreted as an indicator and all subjects gave written informed consent for this of acute lesions (Wolinski et al., 1990; Larsson et al., 1991; Narayana et al., 1992 Davie et al., 1993 Davie et al., , 1994  investigation.
In an acute multiple sclerosis lesion, an incidentally
MRI and spectroscopy
diagnosed lipoma of the corpus callosum of the same patient Both MRI and 1 H MRS were performed on a 1.5 T whole and in one control, T 1 measurements of the resonance at body system. The study commenced with an axial native T 1 -0.9 p.p.m. were performed by Tl variation. Inversion times weighted spin-echo sequence [repetition time (TR) 600 ms, of 100-4000 ms and a constant delay of 3000 ms between echo time (TE) 12 ms, 5 mm slice thickness with a 0.5 mm radio-frequency excitation and successive inversion pulse gap, 192 ϫ 256 matrix, one acquisition] and an axial T 2 -were used. The T l relaxation times were calculated from the weighted turbo spine-echo sequence [TR 5600 ms, effective fits of the spectral signal intensity. echo time (TE eff ) 119 ms, echo train length 15, 5 mm slice thickness with a 0.5 mm gap, 210 ϫ 256 matrix, three
The normality of the distributions of metabolite and macroAll patients received intravenous contrast medium (gadomolecule concentrations in all three groups-acute lesions, linium-DTPA) (Magnevist; Schering, Berlin, Germany) for chronic lesions and control subjects-was determined with the contrast-enhanced T 1 -weighted images. Contrast medium was Kolmogorov-Smirnov test. Metabolite and macromolecule applied at least 24 h before 1 H-MRS in five patients with concentrations in all three groups were compared by analysis acute and eight patients with chronic multiple sclerosis, 4 h of variance (ANOVA), including Bonferroni correction for before 1 H-MRS in three patients with acute lesions and multiple comparisons. 20 min before 1 H-MRS in two patients with acute and two with chronic multiple sclerosis. The effects of contrast medium on the spectra were studied 1 day after contrast Results medium application in one patient with acute and one patient
Effects of contrast enhancement and steroid
with chronic multiple sclerosis.
treatment
In the patients with acute multiple sclerosis, the known No substantial changes between the spectra 1 h and 1 day contrast-enhancing lesions were selected for spectroscopy; after contrast-enhancement were found ( Fig. 2C ), nor were all were located in the supratentorial white matter. Lesions differences found between spectra obtained before, during that appeared non-enhancing on T 1 -weighted hypointense and after a 5-day course of corticosteroid treatment (Fig. 2D ). and on T 2 -weighted hyperintense imaging were investigated All these spectra were obtained from a 19-year-old male with in the supratentorial deep white matter of patients with acute multiple sclerosis and an 8-day history of a hemiparesis chronic multiple sclerosis. In the controls, the cubic VOI of sensory and motor functions. A representative contrastwas placed in the supratentorial deep white matter of the enhanced T 1 -weighted image, showing a ring-shaped parieto-occipital region. The voxel size was always 8 ml.
enhancing lesion in the left internal capsule (arrow) and a 1 H-MRS was performed with a self-designed single-voxel lipoma of the corpus callosum (dotted arrow) is shown in stimulated echo acquisition mode (STEAM) sequence with Fig. 2A . The VOI and the saturation slices are shown the following parameters: TR 1500 ms; mixing time (TM) in Fig. 2B . 10 ms; TE 15 ms; 128 acquisitions (Seeger et al., 1999) . A hyperbolic secant inversion pulse with an inversion time (TI) Metabolite and macromolecule concentrations of 500 ms was used for metabolite-nulling. For outer volume NAA was significantly reduced in both the acute and the saturation, three pairs of perpendicular saturation slices were chronic multiple sclerosis lesion groups compared with the applied for presaturation of fat-containing regions on each controls (P Ͻ 0.05 for acute and P Ͻ 0.01 for chronic side of the VOI (Seeger et al., 2000) . Lac, NAA, Cr, Cho, lesions). Cho was significantly elevated in acute multiple MI and Glx were quantitated by using the user-independent sclerosis compared with the controls (P Ͻ 0.05). MI showed frequency domain-fitting program LCModel (Provencher a tendency to increase in the group with chronic multiple et al., 1993). For additional quantitation of the macrosclerosis but this did not reach significance. The other molecular resonances, LCModel was modified. Averaged metabolite concentrations did not reveal any significant metabolite-nulled spectra of white matter in 10 healthy differences between the acute, chronic and control groups. volunteers and 10 acute multiple sclerosis lesions acquired
The metabolite and macromolecule concentrations are given with outer volume saturation were parameterized in each in Table 1 . case with resonance lines at 0.9, 1.3, 2.1 and 3.1 p.p.m.
The macromolecular resonance at 0.9 p.p.m. was These independent curves were added to the initial basis significantly elevated in the acute group compared with the set of 15 metabolite model spectra of the LCModel. The chronic group and the controls (P Ͻ 0.001 in each case). parameterized resonances were found to have a broader line
The resonance at 1.3 p.p.m. was significantly elevated in width than the metabolites and could be used to give a acute lesions compared with chronic lesions and healthy sufficient fit of the macromolecules. The in vivo STEAM controls (P Ͻ 0.05 in each case). The macromolecular spectra without metabolite-nulling were fitted with the resonances at 2.1 and at 3.1 p.p.m. did not differ significantly extended basis set, resulting in absolute concentrations of between the groups. Examples of spectra from an acute multiple sclerosis metabolites and macromolecules, the latter in arbitrary units. The absolute values of the metabolites corresponded to controls, P Ͻ 0.001; § acute lesions versus chronic lesions and millimolar concentrations, but they underlie a certain amount healthy controls, P Ͻ 0.05.
of T 1 saturation due to the TR of 1500 ms. Thus, they are shown only as arbitrary units in Table 1 . This should be lesion, a chronic lesion and a control are displayed in Fig. 3 .
taken into account in comparisons with published results. In the STEAM spectrum of the acute lesion (Fig. 3A, top The definition of acute multiple sclerosis lesions is still a trace), two prominent resonances were visible, one at 0.9 matter of controversy. An acute onset of clinical symptoms, and one at 1.3 p.p.m. After application of the inversion and contrast-enhancement are criteria for the acute phase pulse of the metabolite-nulling technique (middle trace), the of lesion development. Enhancement usually accompanies 0.9 p.p.m. resonance was more prominent than that at inflammation (Katz et al., 1993; Lucchinetti et al., 1996 ; 1.3 p.p.m. because of intensity nulling of Lac. Subtraction Brück et al., 1997; Miller et al., 1998) . Thus, we chose acute of the two spectra (bottom trace) showed the presence of the clinical onset of symptoms accompanied by a contrastLac doublet at 1.33 p.p.m. The metabolite-nulled spectra of enhancing lesion as criteria for an acute lesion. the chronic lesion did not differ from that of the healthy Effects of contrast media on the spectra are critical issues. control. The NAA peak of the chronic lesion was reduced, At long echo times, a reduction of Cho, unchanged NAA while the Cho peak and the MI peak were increased compared and Cr (Sijens et al., 1998) and no changes in metabolites with the control (Fig. 3B and C) . (Smith, et al., 2000) have been reported. In short echo-time spectra, contrast media showed no effects (Narayana et al.,
Spectra of the lipoma
1992; Taylor et al., 1995; Sijens et al., 1998) . To investigate The lipoma was chosen to compare the spectrum of human possible influences of contrast media on our short echo-time lipids with the macromolecular resonances of the brain. spectra, a follow-up was performed in one chronic and one Figure 4A shows the T 1 -weighted images of the investigated acute patient 1 day after contrast application. No substantial curvilinear lipoma of the corpus callosum. The spectra of changes were observed in these spectra. This supports the the lipoma (Fig. 4B ) exhibited three resonances: the 0.9 p.p.m.
latter observation. resonance of the methyl CH 3 groups, the 1.3 p.p.m. resonance Effects of corticosteroid treatment on the spectra have of the methylene (CH 2 ) n groups and the 2.1 p.p.m. resonance been described as a reduction in the MI/Cr ratio (Auer et al., of the terminal methylene groups (Schick et al., 1993) . The 1997) and, in patients with Cushing's syndrome, a reduction peak of the methylene groups at 1.3 p.p.m. was seven-fold in the Cho/Cr ratio (Khiat et al., 1999) . In both studies, higher than that of the methyl groups at 0.9 p.p.m. In contrast metabolite ratios were considered and it is not clear whether to the spectrum of the lipoma, the macromolecular pattern these changes would also occur if an absolute quantitation of the acute multiple sclerosis lesion (Fig. 4B) was different; were applied. In our study, the follow-up of one acute patient the peak intensities of the methylene and methyl groups were did not reveal changes in the spectra, so that two patients nearly equal, indicating a different chemical composition.
with corticosteroid treatment were allowed in the study.
T 1 measurements
The T 1 relaxation curves of the macromolecules at 0.9 p.p.m. revealed a T 1 time of 218 ms in the acute lesion and a T 1
Metabolites and macromolecules
The reduction of NAA in acute and chronic lesions compared time of 185 ms in the healthy control. The T 1 relaxation time of the corresponding resonance of the lipoma was with controls was in agreement with other studies and was Fig 3 (A) T 1 -weighted contrast-enhanced and T 1 -weighted axial turbo spin-echo images of a 25-year-old female multiple sclerosis patient with a small acute contrast-enhancing and a large corresponding hyperintense lesion in the left occipital periventricular white matter. The saturation slices and the position of the 8 ml volume of interest (VOI) are indicated. Line 1, STEAM spectrum (TR 1.5 s, TM 10 ms, TE 15 ms); line 2, metabolite-nulled spectrum (TR 1.5 s, TM 10 ms, TE 15 ms, TI 500 ms); line 3, difference spectrum. The STEAM spectrum reveals reduced NAA and elevated MI. The macromolecules at 0.9 p.p.m. have nearly the same height in the STEAM and metabolite-nulled spectra. The resonance at 1.3 p.p.m. is lower on the metabolite-nulled spectrum because of intensity-nulling of Lac, which is clearly visible on the difference spectrum. (B) T 2 -weighted axial turbo spin-echo image of a 35-year-old female multiple sclerosis patient. The VOI contains a chronic lesion in the right periventricular white matter. In the STEAM spectrum, decreased NAA and elevated MI are visible (lines 1 and 3); the macromolecules in the metabolite-nulled spectrum are normal (line 2). (C) T 2 -weighted axial turbo spin-echo image of a 31-year-old male healthy control. The VOI contains normal white matter. STEAM spectrum, metabolitenulled spectrum and difference spectrum.
interpreted as axonal loss or axonal dysfunction by these et al., 2000) . Increased Cho in acute lesions and elevated MI in chronic lesions have been described (Bruhn, et al., authors (Miller et al., 1998; Sarchielli et al., 1998; Bitsch et al., 1999; Brex et al., 1999; Kornek 1992; Davie et al., 1993 Davie et al., , 1994 Koopmans et al., 1993 ; Brex et Sarchielli et al., 1999) . The significantly elevated was reduced, because of intensity nulling of the Lac that was present. In the difference spectra, Lac was visible at Cho in acute lesions compared with controls in the present study was in agreement with the literature, whereas the 1.33 p.p.m. Thus, the metabolite-nulling technique is necessary in order to determine the true proportions of Lac non-significantly elevated MI only slightly resembled the previously published results.
and macromolecules at 1.3 p.p.m. The elevation of the macromolecules at 0.9 and 1.3 p.p.m. sclerosis lesions (185 and 218 ms, respectively) were similar In the literature, elevated lipids in acute multiple sclerosis to the measured T 1 relaxation time of 250 ms at 2.1 T lesions have been found to vary in the spectral regions of published by Behar and colleagues (Behar et al., 1994) . The their occurrence. They have been reported to lie between 0.8 T 1 relaxation time of the corresponding resonance of the and 1.5 p.p.m. (Wolinski et al., 1990) , between 0.9 and lipoma (583 ms) was much longer and obviously did not 1.4 p.p.m. (Larsson et al., 1991) , between 0.5 and 2.0 p.p.m.
arise from the same molecular source. (Narayana et al., 1992 and between 0.8 and 2.0 p.p.m.
The spectrum of the lipoma of the corpus callosum showed (Koopmans et al., 1993) . According to our own experience, a spectral pattern that was strikingly different from the broad resonances between 0.5 and 2.0 p.p.m. can be linked metabolite-nulled spectra of the acute lesion (Fig. 4B ). Human in whole or in part to lipid contamination from outside the lipids possess a methylene resonance at 1.3 p.p.m. and a VOI if appropriate outer volume saturation is not applied. methyl resonance at 0.9 p.p.m. (Callies et al. 1993 ; Schick Davie and colleagues (Davie et al., 1993 (Davie et al., , 1994 (Davie et al., ) found a lipid et al., 1993 . Because of the chemical composition of lipids, peak at 0.9 and at 1.3 p.p.m., whereas Roser and colleagues the methylene resonance is seven-to eight-fold higher than (Roser et al., 1996) described only one significant peak, at the methyl resonance. In the present study, the resonances of 1.3 p.p.m. In agreement with Davie and colleagues (Davie macromolecules at 0.9 and 1.3 p.p.m. in acute multiple et al., 1993, 1994) , we also found elevated peaks at 1.3 and sclerosis lesions had nearly the same height, indicating that 0.9 p.p.m. without metabolite-nulling. Interestingly, after the the methyl and methylene groups are not only due to a lipid component. application of metabolite-nulling the 1.3 p.p.m. resonance
The three-fold longer T 1 relaxation time of lipids than discrimination among acute and chronic multiple sclerosis lesions and healthy controls. that of macromolecules, and the difference in chemical composition between lipids and the elevated macromolecules lead to the conclusion that the elevated resonances seen in acute lesions were not due entirely to lipids but might also
